BloodThinnerHelp.com reports today on the specifics of wrongful death lawsuits filed in the Xarelto litigation. Lawsuits filed allege that Xarelto causes severe internal bleeding which can further lead to serious injuries and unfortunately death in too many cases. So many of these lawsuits have been filed that in December 2014 a motion was made to consolidate the lawsuits into a multidistrict litigation. The Xarelto MDL currently has more than 1,200 lawsuits filed in it, many of them wrongful death lawsuits. More detailed information about the Xarelto litigation can be found on this page.
Wrongful Death Lawsuit Allegations:
Specifically, the Xarelto lawsuits allege that the drug causes uncontrollable internal bleeding which leads to serious injury or death, that the manufacturers of Xarelto failed to warn doctors and patients about the true dangers of the drug, and that the manufactures were negligent in releasing the drug to market without also releasing a corresponding antidote. Xarelto’s lack of corresponding antidote makes the drug very dangerous to its users because if the patient suffers from an internal bleeding injury, there is no way to stop the bleeding. This can lead to life changing serious injuries and even death.
Wrongful Death Lawsuits Filed By Families of Deceased:
The estate of the deceased and their families have the right to bring forward a Xarelto wrongful death lawsuit if they feel that Xarelto was the proximate cause of their loved ones untimely death. These lawsuits are filed against the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, a subdivision of Johnson&Johnson. Wrongful death lawsuits can be brought forward to seek compensation for medical expenses from the deceased’s treatment, funeral and burial expenses, loss of financial support and wages while the deceased was ill, future losses, and loss of companionship.
FDA Releases Warnings Regarding Xarelto:
Xarelto was initially approved by the Food and Drug Administration, FDA, in 2011 to treat atrial fibrillation, deep vein thrombosis, and to be used in patients who have recently undergone hip or knee replacement surgery. Soon after its release, studies began to show links between Xarelto and serious internal bleeding and lawsuits making these allegations began to be filed. The FDA currently has two black box warnings attached to Xarelto. The black box warning is the most strict warning the FDA can assign to a drug short of recalling it. It means that there is a reasonable risk of harm associated with taking the medication.
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.
###
Contact BloodThinnerHelp.com:
Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.
